STOCK TITAN

Polyrizon Ltd. (PLRZ) Financials

PLRZ
FY2025 annual
Net Income -$3.3M -115.9% YoY
EPS (Diluted) $4.90 YoY not available
Free Cash Flow -$4.5M YoY not available
Operating Cash Flow -$4.5M -294.8% YoY
Market Cap $22.2M as of Oct 7, 2026
Price / Sales n/m no revenue reported
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 1.1x on $21.0M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 7, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Mar 25, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PLRZ SEC filings page.

This page shows Polyrizon Ltd. (PLRZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

Polyrizon Ltd. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
3/6

Polyrizon Ltd. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing
N/A

Polyrizon Ltd. reported a net loss of $3.3M while operations used $4.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Polyrizon Ltd. reported an operating loss of $6.2M against $370K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$1.3M
YoY-48.9%
QoQ-91.7%

Polyrizon Ltd. held $1.3M in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding
2M

Polyrizon Ltd. had 2M shares outstanding in Q4 2025.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

PLRZ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLRZ quarterly income statement
MetricQ4'2520-FQ2'256-KQ4'2420-FQ4'2310-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

PLRZ Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLRZ quarterly balance sheet
MetricQ4'2520-FQ2'256-KQ4'2420-FQ4'2310-K
Total Assets$21.4M+286.5%$18.7M$5.5M+892.3%$559K
Current Assets$12.9M+384.7%$16.0M$2.7M+4813.0%$54K
Cash & Equivalents$1.3M-48.9%$15.8M$2.6M+63750.0%$4K
Short-Term Investments$0$0$0-100.0%$37K
Long-Term Investments$0$0$0$0
Total Liabilities$443K+69.7%$364K$261K-65.2%$750K
Current Liabilities$443K+69.7%$364K$261K-48.0%$502K
Non-Current Liabilities$0$0$0-100.0%$248K
Total Equity$21.0M+297.2%$18.4M$5.3M+2867.5%-$191K
Retained Earnings-$8.4M-65.8%-$5.2M-$5.1M-43.9%-$3.5M

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

PLRZ Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLRZ quarterly cash flow statement
MetricQ4'2520-FQ2'256-KQ4'2420-FQ4'2310-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

PLRZ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLRZ quarterly financial ratios
MetricQ4'2520-FQ2'256-KQ4'2420-FQ4'2310-K
Current Ratio29.03+18.9x44.0410.16+10.1x0.11
Debt-to-Equity0.020.0x0.020.05N/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Polyrizon Ltd. PLRZ FY2025 N/A -$3.3M N/A $22.2M —
TITAN PHARMACEUTICAL INC TTNP FY2024 N/A -$4.7M N/A $6.1M —
Silo Pharma, Inc. SILO FY2025 $72K -$4.2M N/A $3.0M —
Ensysce Biosciences, Inc. ENSC FY2025 $5.1M -$10.2M N/A $8.4M 59/100
60 Degrees Pharmaceuticals, Inc. SXTP FY2025 $1.0M -$7.4M N/A $3.9M 57/100
ADITXT INC ADTX FY2025 $3K -$43.1M N/A $34K —

Frequently Asked Questions

Is Polyrizon Ltd. profitable?

No, Polyrizon Ltd. (PLRZ) reported a net income of -$3.3M in fiscal year 2025.

What is Polyrizon Ltd.'s earnings per share (EPS)?

Polyrizon Ltd. (PLRZ) reported diluted earnings per share of $4.90 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Polyrizon Ltd.'s EBITDA?

Polyrizon Ltd. (PLRZ) had EBITDA of -$5.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Polyrizon Ltd. (PLRZ) has a return on equity of -15.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Polyrizon Ltd. (PLRZ) recorded an outflow of $4.5M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Polyrizon Ltd. (PLRZ) recorded an outflow of $4.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Polyrizon Ltd. (PLRZ) had $21.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Polyrizon Ltd. (PLRZ) invested $7K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Polyrizon Ltd. (PLRZ) invested $2.1M in research and development during fiscal year 2025.

Polyrizon Ltd. (PLRZ) had 2M shares outstanding as of fiscal year 2025.

Polyrizon Ltd. (PLRZ) had a current ratio of 29.03 as of fiscal year 2025, which is generally considered healthy.

Polyrizon Ltd. (PLRZ) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Polyrizon Ltd. (PLRZ) had a return on assets of -15.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Polyrizon Ltd. (PLRZ) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $22.2M as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Polyrizon Ltd. (PLRZ) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $22.2M as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Polyrizon Ltd. (PLRZ) held $1.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $4.5M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Polyrizon Ltd. (PLRZ) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Polyrizon Ltd. (PLRZ) reported a net loss of $3.3M while operations used $4.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Polyrizon Ltd. (PLRZ) reported an operating loss of $6.2M against $370K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top